Replication-competent ecotropic Friend murine leukemia virus (F-MuLV) induces a high incidence of fatal erythroid and myeloid and lymphoid proliferative diseases in mice of susceptible strains (1, 6, 9, 18, 20, 24, 26, 27, 31, 32) . F-MuLV and a number of other ecotropic viruses are able to recombine in some strains of mice with endogenous retroviral sequences to generate recombinant dual-tropic mink cell focus-forming (MCF) viruses (4, (11) (12) (13) (14) . It is still unclear which virus(es), F-MuLV or Friend MCF, is responsible for induction of the disease observed shortly after inoculation of F-MuLV. In the present study we compared F-MuLV 57, a highly virulent strain isolated by molecular cloning (19, 32) , and F-MuLV B3 (17) , a biological clone obtained from the same original stock as F-MuLV 57 but exhibiting a low virulence when inoculated into newborn mice of susceptible strains (6, 17) .
F-MuLV 57 and B3 were originally obtained from E. M. Scolnick (Merck Sharp & Dohme, West Point, Pa.) and propagated in chronically infected Fischer rat embryo cells. The molecularly cloned Moloney murine leukemia virus (M-MuLV) strain 1387 (17) was propagated in Mus dunni cells (16) . Virus stocks were titered by using a previously described focal immunofluorescence assay (FIA) on M. dunni cells with the appropriate monoclonal antibody (7, 30) . The origins of the cell lines used in this study have been previously described (30) .
Structural similarities between F-MuLV 57 and B3. To determine if obvious genomic differences between F-MuLV B3 and 57 existed, we compared the RNase T1-resistant oligonucleotide fingerprints of the virion RNAs, as previously described (11) . The large oligonucleotides of these two strains were indistinguishable (Fig. 1 RNase T1 and fingerprinted, and oligonucleotides were numbered as previously reported (11) . Electrophoresis was from left to right, and homochromatography was from bottom to top.
inoculated with F-MuLV B3 did not decrease to this level until more than 4 months after inoculation. Replication of F-MuLV 57 and B3 in newborn-inoculated mice. To determine whether the low virulence of F-MuLV B3 was caused by an inability of this virus to replicate efficiently in vivo, spleen cells from newborn-inoculated mice were assayed for production of virus at various times after inoculation. Ecotropic F-MuLV infectious centers (IC) were detected on either SC-1 or M. dunni cells, which appeared to be equally susceptible to F-MuLV infection. In all cases, the detection of IC was carried out on live cell monolayers with the FIA with ecotropic-specific monoclonal antibody 48 (7, 30) . The number of ecotropic F-MuLV IC observed in the spleens of mice given F-MuLV 57 or B3 was similar from 1 week to 3 months after inoculation (Fig. 3) . By this time, most of the F-MuLV 57-inoculated mice had succumbed, and the number of F-MuLV B3 IC remained at the same level until the mice succumbed. No correlation was found between spleen size and the IC titers (data not shown). Therefore, the difference in virulence observed between F-MuLV 57 and B3 was not because of an inability of F-MuLV B3 to replicate in vivo. Plasmas of IRW and NFS/N mice inoculated as newborns with F-MuLV 57 or B3 were assayed for the presence of anti-F-MuLV gp7O antibodies by using a 1251-labeled protein A-binding assay (22) and for presence of infectious F-MuLV by using the FIA on M. dunni cells. No detectable anti-F-MuLV antibody response was found in IRW and NFS/N mice 1 to 7 months after inoculation of newborns with either virus, and similar levels of viremia were found in F-MuLV 57-and B3-inoculated mice (104 to 106 FFU/ml of plasma). Therefore, the different virulences of F-MuLV 57 and B3 were not due to a difference in the elicitation of the immune response sive to both dual-tropic MCF viruses and ecotropic F-MuLV (16), both pseudotyped and unpseudotyped MCF viruses could be detected (29) . We observed that F-MuLV B3-inoculated mice were positive for MCF IC as early as F-MuLV 57-inoculated mice (Fig. 4) . The appearance of MCF IC in both cases was independent of splenomegaly (data not shown), and the number of MCF IC present in the spleens of mice inoculated with F-MuLV 57 or B3 was similar at all times studied (Fig. 4) . Different families of Friend MCF and Moloney MCF viruses have been identified by virus RNA fingerprinting and by their reactivity with monoclonal antibodies (11, 12) . Moreover, it has been shown that different ecotropic murine leukemia viruses may preferentially induce different types of MCF viruses (11, 12) . With a panel of nine monoclonal antibodies reacting with MCF viruses, we found that MCF IC detected after inoculation with F-MuLV 57 or B3 had an identical pattern of reactivity (Table 1 ). In addition, RNA fingerprinting analysis of one F-MuLV B3-induced MCF virus identified the endogenously derived oligonucleotides characteristic of F-MuLV 57-induced MCF viruses (X12, X37, X39, X40, X41, X42) (11, 12) . These data indicated that F-MuLV B3-induced MCF viruses were generated by recombination with the same endogenous sequences found in F-MuLV 57-induced MCF viruses. Therefore, it is unlikely that the differences in virulence observed between F-MuLV 57 and B3 was because of a qualitative or quantitative difference in the induction of recombinant MCF viruses.
Cell types in enlarged spleens from F-MuLV 57-and B3-inoculated mice. Another explanation for the differences in virulence is the possible inability of F-MuLV B3 to induce erythroid proliferative disease. Therefore, we analyzed the different cell types present in enlarged spleens after inoculation with F-MuLV 57 or B3. At different times after infection, splenomegalic mice were killed, and single spleen cell suspensions were processed for staining with Giemsa, Sudan black, and nonspecific esterase reactions as previ- F-MuLV 57
a NFS/N mice were inoculated intraperitoneally within 48 h after birth. Spleen or thymus IC were seeded on M. dunni cells. Fluorescent foci were detected 4 to 6 days later by using an FIA (30) with the different monoclonal antibodies.
I All monoclonal antibodies react with envelope antigens of MCF from different origins (5) (6) (7) 12) . +, Presence of fluorescent foci; -, absence of fluorescent foci; ±, dim fluorescent foci were sometimes observed. ously described (6) . Because spleens from control mice had less than 5% erythroid or myeloid cells, enlarged spleens with more than 10% of erythroid or myeloid cells were considered positive for erythroid or myeloid proliferative diseases. If more than 80% of the cells were not erythroid or myeloid, the proliferative disease was designated as lymphoid. We found that splenomegaly in mice inoculated with F-MuLV 57 was caused by an increased frequency of erythroid cells in 96% of the cases (Table 2 ). Erythroid cells in these spleens ranged from 30 to 95% of the total cells. Abnormal myeloid cell distribution was sometimes observed, but was generally associated with an abnormal erythroid cell distribution (Table 2) . No abnormal lymphoid distributions were observed in this group. In the case of F-MuLV B3-inoculated mice, the involvement of nonerythroid cells in spleen enlargement was more frequent than with F-MuLV 57. Neverthelsss, the majority (61%) of FMuLV B3-inoculated mice had erythroid proliferative disease. Therefore, this virus strain was able to induce a significant incidence of erythroleukemias. Different factors have been described which can influence the type of cell induced to proliferate after inoculation with murine leukemia viruses. The virus strain and more specifically the long terminal repeat and the envelope genes seem to play a role in the cell specificity of leukemia (2, 3, 10, 15, 21) . However, the mouse strain (6, 24, (26) (27) (28) 33) and the age of inoculation (8, 33) also influence the type of disease induced after inoculation with F-MuLV. It is still not clear what mechanisms determine the type of cell proliferation after inoculation with F-MuLV 57 or B3. It seems that a longer latency of disease observed in relatively resistant strains of mice inoculated as newborns or after inoculation of susceptible strains of mice as adults favors a more frequent involvement of nonerythroid proliferation (27, 33; P. Tambourin, personal communication). Also in agreement with this observation is our finding that incidence of nonerythroid leukemias, particularly lymphoid leukemias, was increased in mice inoculated with F-MuLV B3, which had a longer latency of disease.
The present results suggest that the generation of recombinant F-MCF viruses is not sufficient to induce early splenomegaly observed with F-MuLV 57 and other fully virulent strains of F-MuLV, since F-MuLV B3 did induce Friend MCF viruses as efficiently as F-MuLV 57. Since F-MuLV B3 induced only late leukemias, whereas F-MuLV 57 and other fully virulent strains of F-MuLV are able to induce both early splenomegaly and late transplantable leukemias (6, 18, 20, 26, 32, 33) , it is likely that the pathogenic effect of F-MuLV 57 which leads to induction of VOL. 57, 1986 on October 28, 2017 by guest http://jvi.asm.org/ Downloaded from 
